Abstract
As recently as 30 years ago, macular holes were thought to be untreatable. Kelly and Wendel showed that this was not the case in 1991 when they published their pilot study on vitreous surgery for idiopathic macular holes1. In 1997, Eckardt et al. introduced internal limiting membrane (ILM) peeling2, following which, pars plana vitrectomy, internal limiting membrane peeling, fluid/gas exchange and face-down positioning were soon adopted as the standard treatment method for successful hole closure and BCVA improvement. Surgeons improved their own results by using smaller gauge instruments and, especially, by more qualified patient selection: earlier treatment, non-myopic eyes, better initial visual acuity, and smaller macular holes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
